Anthracycline chemotherapy (doxorubicin, epirubicin) and left-sided radiotherapy can affect cardiac function years after treatment ends
Dyspnea, tachyarrhythmias Increased blood pressure, widened pulse pressure Aortic systolic murmur Congestive heart failure Heart Failure A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body
The FDA warns against off-label uses, so its important to take medication as intended
The therapeutic stability window for most lyophilised peptides, including 5-Amino-1MQ, is 1025mg/mL this range balances solubility, aggregation prevention, and minimal oxidative exposure throughout the 28-day refrigerated lifespan
Symptoms could include muscle weakness, a tingling sensation, numbness, trouble catching your breath, racing heart, nausea, chest pain, and vomiting